FAQs — Liquistat™ Database
What
is the "discount for lack of marketability"?
The
discount for lack of marketability is also often referred
to as the DLOM, the marketability discount, or the illiquidity
discount. It refers to the difference in the fair market
values between two otherwise-identical securities, one that
is fully liquid and one that suffers from some degree of
illiquidity.
Why
are illiquid assets and securities always worth less than
fully-liquid ones?
The theoretical underpinnings
of the illiquidity discount is actually not very well
understood. One Tax Court opinion merely states that it
is "axiomatic" that investors always pay less for illiquid
securities. Conceptually, investors value liquidity and
would be concerned about possible losses if forced to
hold a security, in particularly a risky security.
What
are the methods used to determine discounts for lack of
marketability?
The illiquidity discount can
be determined through theoretical models or a review of
empirical discount studies and data. For a more thorough
discussion of the strengths and weaknesses of each method,
please go to our Press Room
. The empirical data analyzed
are based on either restricted stock transactions or pre-IPO
transactions. The pre-IPO transactions have significant
biases that have been discussed in published research
and highlighted in the McCord Tax Court decision.
Prior to the launch of Pluris and the creation of the
LiquiStat ™ database, all published restricted stock
studies were studies of private placements. Unfortunately,
all private placement studies in peer-reviewed academic
financial journals have explained private placement discounts
as having little or nothing to do with illiquidity. While
this debate is clearly still unresolved, we believe that
the pricing of private placements is subject to too many
factors that are unrelated to the liquidity of the shares
sold. So while these older studies are a reasonable starting
point for any analysis, better transaction data is required.
To discuss the various methods for determining illiquidity
discounts and how we apply the LiquiStat data in our work,
please e-mail us .
What
are restricted stock private placement studies?
All "restricted stock studies"
published up until the creation of the LiquiStat &trade database
are, in reality, private placement studies. The peculiarities
of the private placement process produce pricing effects
that may be unrelated to illiquidity. For a discussion
on the strengths and shortcomings of using private placement
data to determine marketability discounts, please go to
our Press Room, or e-mail us if you have any questions.
What
is restricted stock?
Restricted stock is stock held
by an affiliate of the issuer or stock that has been
sold by the issuer or an affiliate of the issuer, without
registration. Such stock can be sold only if an exemption
from the registration requirement can be found. Restricted
stock can only be sold in the public markets by complying
with Rule 144 of the SEC. This requires, at a minimum,
a holding period of six months. However, restricted stock
can be sold prior to the expiration of the holding period
in private transactions.
How
are pre-IPO studies and restricted stock private placement
studies different?
Pre-IPO studies analyze the difference
in stock prices between stock issued by private companies
and stock subsequently issued in initial public offerings
(IPOs) by the same companies. This analysis has several
problems, as highlighted in a paper by Dr. Bajaj [Mukesh
Bajaj, David J. Denis, Stephen P. Ferris and Atulya Sarin:
"Firm Value and Marketability Discounts," Journal of
Corporation Law, Fall 2001].
Anyone who is allowed to purchase
common shares in a pre-IPO company is likely to be an
insider or someone else who provides services to the firm.
The only arm's-length transactions in pre-IPO shares are
typically between the issuing firm and certain venture
capital investors. Those investors generally buy preferred
shares, not common shares. In addition, the pre-IPO transaction
sample is inherently biased, because it only includes
firms that successfully complete their IPOs. These arguments
were reviewed and accepted by the Tax Court in the McCord decision.
How
is the LiquiStat™ database unique?
The LiquiStat&trade database is the
first-ever study of illiquidity discounts in transactions
between individual shareholders. Because these transactions
do not involve the issuer at all (they are not private
placements), the pricing of securities in these transactions
is less subject to factors other than the intrinsic characteristics
of the shares sold.
As a result, the difference in
price between the restricted stock sold and the exact
same security trading in the financial markets should
be due almost exclusively to the illiquidity of the restricted
stock, rather than other factors. Other factors that affect
price in private placement studies include:
Information asymmetry
(the "lemons problem" arising when insiders
try to sell something to outsiders)
Capital scarcity
(the fact that most companies doing private placements
are in dire straits financially and desperately need cash)
Control and monitoring
effects (the positive effect on the firm's value from
the monitoring services performed by very large shareholders)
These factors, which are unrelated
to the illiquidity of the stock, are all present, to a
lesser or greater extent, in private placements, but not
in arm's-length investor trades between two investors
that are unrelated to the stock's issuer. The transactions
in the LiquiStat&trade database are all arm's-length transactions
from the SecondMarket trading platform.
What
is the SecondMarket trading platform?
The SecondMarket trading platform, which is used to trade illiquid assets, is operated by SecondMarket,
of New York, NY.
How
many transactions are in the LiquiStat database?
The LiquiStat database includes thousands of transactions, which is significantly more than the number used in most valuation studies. With dozens of transactions being added each month, the database is growing rapidly.
What
are the main conclusions you have drawn from analyzing the
LiquiStat database?
Please visit our Press Room for
articles, white papers and other information on the results
of our analysis.
Briefly, our analysis to date has modeled restricted-stock
discounts based on factors such as the volatility (variance)
of the stock price, the size of the block of shares sold,
the stock's trading price in the market and -- very importantly
-- the time period left until the restrictions on the
stock expire.
The research has revealed an upward-sloping, but concave,
relationship between the number of days of illiquidity
remaining and the discount. For warrants, our research
has modeled both discounts from the total warrant Black-Scholes
model value and discounts from the Black-Scholes model
time premium. The discounts have been modeled on factors
such as the volatility of the stock, the delta of the
warrant, a measure of how far the option is in or out
of the money, the market value of the issuing firm, block-size
measures and other factors. For questions regarding the
latest research on the LiquiStat&trade database transactions,
please e-mail us.
|